Notice2025-23450

CAUTI Events Among Patients With Spinal Cord Injury-Associated Neurogenic Bladder (SCI-NB); Request for Information: Reopening of Comment Period

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 19, 2025

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

The Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services (HHS), is reopening the public comment period for a request for information (RFI) that was initially published on September 8, 2025, regarding Catheter-associated Urinary Tract Infections (CAUTIs) among patients with Spinal Cord Injury-associated Neurogenic Bladder (SCI- NB). We want to understand better the burden of CAUTIs among this patient population and any implications related to reporting within the CDC National Healthcare Safety Network (NHSN) device-associated urinary tract infection (UTI) event module. This docket provides an opportunity for professionals who work with this patient population, as well as those who conduct NHSN UTI surveillance, to offer feedback related to our approach.

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 242 (Friday, December 19, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 242 (Friday, December 19, 2025)]
[Notices]
[Pages 59522-59524]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-23450]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2025-0453]


CAUTI Events Among Patients With Spinal Cord Injury-Associated 
Neurogenic Bladder (SCI-NB); Request for Information: Reopening of 
Comment Period

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Request for information (RFI).

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), in the 
Department of Health and Human Services (HHS), is reopening the public 
comment period for a request for

[[Page 59523]]

information (RFI) that was initially published on September 8, 2025, 
regarding Catheter-associated Urinary Tract Infections (CAUTIs) among 
patients with Spinal Cord Injury-associated Neurogenic Bladder (SCI-
NB). We want to understand better the burden of CAUTIs among this 
patient population and any implications related to reporting within the 
CDC National Healthcare Safety Network (NHSN) device-associated urinary 
tract infection (UTI) event module. This docket provides an opportunity 
for professionals who work with this patient population, as well as 
those who conduct NHSN UTI surveillance, to offer feedback related to 
our approach.

DATES: Comments must be received by February 2, 2026. Comments received 
after this date will not be considered.

ADDRESSES: Submit comments by either of the following methods:
    <bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>. 
Follow the instructions for submitting comments.
    <bullet> Mail: Comments may also be sent by mail to the attention 
of Henrietta Smith, Division of Healthcare Quality Promotion, National 
Center for Emerging and Zoonotic Infectious Diseases, CDC, 1600 Clifton 
Rd. NE, Mail Stop H16-3, Atlanta 30333
    Instructions: All written submissions received in response to this 
document must include the agency name and docket number (CDC-2025-0453) 
for this activity. Please note that comments received, including 
attachments and other supporting materials, are part of the public 
record and are subject to public disclosure. Comments will be posted on 
<a href="https://www.regulations.gov">https://www.regulations.gov</a>. Therefore, do not include any information 
in your comment or supporting materials that you consider confidential 
or inappropriate for public disclosure. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate submissions. Do not 
submit comments by email.

FOR FURTHER INFORMATION CONTACT: Henrietta Smith, RN, MSN, CIC, Lead-
NHSN Protocol and Training Team, Surveillance Branch, Division of 
Healthcare Quality Promotion, by email at <a href="/cdn-cgi/l/email-protection#1a747269745a797e79347d756c"><span class="__cf_email__" data-cfemail="a8c6c0dbc6e8cbcccb86cfc7de">[email&#160;protected]</span></a>. Please include 
the docket number (CDC-2025-0453) and ``CAUTI events among patients 
with Spinal Cord Injury-associated Neurogenic Bladder (SCI-NB)'' in the 
subject line.

SUPPLEMENTARY INFORMATION: On September 8, 2025, CDC published a 
request for information in the Federal Register (90 FR 43187). The 
initial comment period closed on December 8, 2025. To allow interested 
parties additional time to submit comments, CDC is reopening the 
comment period for 45 days. CDC is committed to protecting patients and 
healthcare workers from adverse healthcare events and promoting safety, 
quality, and value in healthcare delivery. Preventing healthcare-
associated infections (HAIs) is a priority for CDC and its partners in 
public health and healthcare. As part of this work, CDC supports 
surveillance of Catheter-associated Urinary Tract Infections (CAUTIs) 
and Non-Catheter-associated Urinary Tract Infections (UTIs) and other 
Urinary System Infections (USIs).
    UTIs are the fifth most common type of HAI, with an estimated 
62,700 UTIs in acute care hospitals in 2015. UTIs account for more than 
9.5% of infections reported by acute care hospitals.\1\ Virtually all 
healthcare-associated UTIs are associated with instrumentation of the 
urinary tract.
    Approximately 12-16% of adult hospital inpatients will have an 
indwelling urinary catheter (IUC) at some time during their 
hospitalization, and each day the IUC remains, a patient has a 3-7% 
increased risk of acquiring a CAUTI.<SUP>2 3</SUP> The outcomes of 
CAUTIs include discomfort to the patient, prolonged hospital stays, and 
other serious health complications, including death.\4\ It has been 
estimated that each year, more than 13,000 deaths are associated with 
UTIs.\5\
    Historically, the National Healthcare Safety Network has not 
collected data that specifically identify which patients with CAUTI 
events have Spinal Cord Injury-associated Neurogenic Bladder (SCI-NB). 
To enhance CDC's understanding of the burden of CAUTIs in this patient 
population, a ``Neurogenic Bladder'' risk factor variable has been 
added within the NHSN application. This variable allows NHSN users to 
indicate whether a CAUTI event occurred in patients with SCI-NB by 
using specific ICD-10-CM diagnosis codes. This new variable is 
currently optional.
    NHSN's current definition of SCI-NB is in Chapter 7-UTI Events of 
the Patient Safety Component (PSC) manual (<a href="https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf">https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf</a>). The SCI-NB ICD-10-CM diagnosis 
codes are available on the NHSN UTI Events web page (<a href="https://www.cdc.gov/nhsn/xls/SCI-NB_ICD-10-CM.xlsx">https://www.cdc.gov/nhsn/xls/SCI-NB_ICD-10-CM.xlsx</a>). Additionally, the 
``Neurogenic Bladder'' variable is accessible within the NHSN 
application (<a href="https://sams.cdc.gov/">https://sams.cdc.gov/</a>).

    Note: The ``Neurogenic Bladder'' variable will be required 
starting January 2026. NHSN's definition of SCI-NB will be expanded 
to include both traumatic and non-traumatic etiologies of spinal 
cord injuries also starting January 2026.

    This docket provides an opportunity for professionals who work with 
the SCI-NB patient population, as well as those who conduct NHSN UTI 
surveillance, to share their perspectives and concerns, which will help 
inform our decisions on the ``Neurogenic Bladder'' variable in the 
future. The CDC is also seeking additional insights into the unintended 
consequences of including the SCI-NB patient population in UTI 
surveillance, and public comments will help guide our approach moving 
forward. Specifically, CDC is interested in receiving information 
related to the following:
    1. What challenges or barriers might the required reporting of 
spinal cord injury-associated neurogenic bladder ICD-10-CM diagnosis 
codes within the NHSN application pose for your facility? How could 
these challenges or barriers be minimized?
    2. Would your facility be able to report the necessary procedure 
code data within 4.5 months of the end of the quarter in which the 
procedure occurred? If not, why not, and what is the shortest amount of 
time following the end of the quarter that the complete data would be 
available?
    3. At your facility, of the patients with spinal cord injury, what 
injury type or condition (ICD-10-CM diagnosis codes can be provided) is 
most strongly associated with CAUTIs?
    4. At your facility, have patients with spinal cord injury-
associated neurogenic bladder experienced harms, complications, or any 
other unintended consequences from efforts to monitor and prevent 
CAUTIs?

References

1. Magill S., O'Leary S. Janelle D., et al. Changes in Prevalence of 
Health Care Associated Infection in the U.S. Hospitals. New England 
Journal of Medicine. 2018;379: 1732-1744.
2. McGuckin M. The patient survival guide: 8 simple solutions to 
prevent hospital and healthcare-associated infections. New York, NY: 
Demos Medical Publishing; 2012.
3. Lo E, Nicolle LE, Coffin SE, Gould C, Maragakis LL, Madding's J, 
et al. Strategies to prevent catheter-associated urinary tract 
infections in acute care hospitals: 2014 update. Infection Control 
and Hospital Epidemiology 2014; 35:464-79.
4. Scott R. The Direct Medical Costs of Healthcare-Associated 
Infections in U.S. Hospitals and the Benefits of Prevention, 2009. 
Division of Healthcare Quality

[[Page 59524]]

Promotion, National Center for Preparedness, Detection, and Control 
of Infectious Diseases, Coordinating Center for Infectious Diseases, 
Centers for Disease Control and Prevention, February 2009.
5. Kelvins, R., Edward, J., et al. Estimating Healthcare-associated 
Infections and Deaths in U.S. Hospitals. Public Health Reports. 
2007;122: 160-166.

Noah Aleshire,
Chief Regulatory Officer, Centers for Disease Control and Prevention.
[FR Doc. 2025-23450 Filed 12-18-25; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on December 19, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.